You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 168 No. 6, March 24, 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System
 •Renal Diseases
 •Renal Diseases, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Definition of Kidney Dysfunction as a Cardiovascular Risk Factor

Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate

Massimo Cirillo, MD; Maria Paola Lanti, MD; Alessandro Menotti, MD; Martino Laurenzi, MD; Mario Mancini, MD; Alberto Zanchetti, MD; Natale G. De Santo, MD

Arch Intern Med. 2008;168(6):617-624.

Background  Urinary albumin excretion (UAE) and estimated glomerular filtration rate (eGFR) have been used separately to provide information about cardiovascular risk. We analyzed whether UAE and eGFR used together provide complementary information.

Methods  We analyzed UAE, eGFR, cardiovascular risk factors, and incidence of cardiovascular disease in 1665 men and women of the Gubbio Population Study (aged 45-64 years). We designated UAE in the highest decile as high (≥ 18.6 µg/min in men and ≥ 15.7 µg/min in women) and eGFR in the lowest decile as low (< 64.20 mL/min/1.73 m2 in men and < 57.90 mL/min/1.73 m2 in women).

Results  Kidney dysfunction defined using both markers was more frequent than using 1 marker (UAE alone or eGFR alone) (P < .001) because high UAE and low eGFR clustered in different individuals and were weakly associated with each other (P = .12). The hazard ratio (HR) for incident cardiovascular disease was elevated for both markers, independently of each other (HR for high UAE, 2.15; 95% confidence interval [CI], 1.33-3.49; HR for low eGFR, 2.14; 95% CI, 1.32-3.48). Kidney dysfunction defined by both markers predicted cardiovascular disease independently of sex, age, hypertension, hypercholesterolemia, smoking, diabetes mellitus, prior cardiovascular disease, left ventricular hypertrophy, and obesity (HR, 1.50; 95% CI, 1.05-2.14). The discriminant power of dysfunction defined by both markers was statistically significant (area under the receiver operating characteristic curve, 0.569 [P = .02]) and slightly higher than what was found with 1 marker of diabetes mellitus, prior cardiovascular disease, left ventricular hypertrophy, and obesity.

Conclusions  High UAE and low eGFR provide complementary information in defining kidney dysfunction because they cluster in different individuals. Concomitant evaluation of both markers should be considered to adequately assess kidney dysfunction and cardiovascular risk.


Author Affiliations: Unit of Nephrology, Second University of Naples (Drs Cirillo and De Santo), and Unit of Internal Medicine, Federico II University (Dr Mancini), Naples; Association for Cardiac Research, Rome (Drs Lanti and Menotti); Center for Preventive Medicine, Gubbio (Dr Laurenzi); and Centro Fisiologia Clinica e Ipertensione, Istituto Auxologico Italiano, Ospedale Maggiore, University of Milan, Milan (Dr Zanchetti), Italy.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men
Nerpin et al.
Nephrol Dial Transplant 2011;26:2820-2827.
ABSTRACT | FULL TEXT  

Albuminuria and Cardiovascular Risk: Time for a New Direction?
Charytan
CJASN 2011;6:1235-1237.
FULL TEXT  

Urinary Albumin Excretion Is Associated With Nocturnal Systolic Blood Pressure in Resistant Hypertensives
Oliveras et al.
Hypertension 2011;57:556-560.
ABSTRACT | FULL TEXT  

Chapter 37 Biomarkers for renal and hepatic failure
Zaninotto et al.
The ESC Textbook of Acute and Intensive Cardiac Care 2010;1:med-9780199584314-chapter-med-9780199584314-chapter.
ABSTRACT | FULL TEXT  

Epidemiology of CKD in Europe: an uncertain scenario
Zoccali et al.
Nephrol Dial Transplant 2010;25:1731-1733.
FULL TEXT  

Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly
Rifkin et al.
Nephrol Dial Transplant 2010;25:1560-1567.
ABSTRACT | FULL TEXT  

Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
de Boer et al.
Diabetes Care 2009;32:1833-1838.
ABSTRACT | FULL TEXT  

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Ninomiya et al.
J. Am. Soc. Nephrol. 2009;20:1813-1821.
ABSTRACT | FULL TEXT  

Glomerular filtration rate and serum phosphate: an inverse relationship diluted by age
Cirillo et al.
Nephrol Dial Transplant 2009;24:2123-2131.
ABSTRACT | FULL TEXT  

Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults
Anderson et al.
J. Am. Soc. Nephrol. 2009;20:1199-1209.
ABSTRACT | FULL TEXT  

How should proteinuria be detected and measured?
Lamb et al.
Ann Clin Biochem 2009;46:205-217.
ABSTRACT | FULL TEXT  

Early identification and management of chronic kidney disease: summary of NICE guidance
Crowe et al.
BMJ 2008;337:a1530-a1530.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.